A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
about
Plasmodium falciparum: multifaceted resistance to artemisininsRecent advances in malaria genomics and epigenomicsArtemisinin Action and Resistance in Plasmodium falciparumLongitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistancePlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.The Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction.Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro.The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Exert Inverse Selective Pressure on Plasmodium Falciparum Drug Sensitivity-Associated Haplotypes in Uganda.A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug PiperaquineThe clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination.STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria.Vaccine candidate discovery for the next generation of malaria vaccines.Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient.Continued Sensitivity of Plasmodium falciparum to Artemisinin in Guyana, With Absence of Kelch Propeller Domain Mutant Alleles.Malaria incidence in Myanmar 2005-2014: steady but fragile progress towards elimination.Household clustering of asymptomatic malaria infections in Xepon district, Savannakhet province, Lao PDRGenetic diversity of the Pvk12 gene in Plasmodium vivax from the China-Myanmar border area.Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast AsiaReduction in malaria prevalence and increase in malaria awareness in endemic districts of BangladeshCharacterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in MalawiEmerging polymorphisms in falciparum Kelch 13 gene in Northeastern region of India.The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia.Malaria epidemiology in central Myanmar: identification of a multi-species asymptomatic reservoir of infection.Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in UgandaRapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.Overlap Extension Barcoding for the Next Generation Sequencing and Genotyping of Plasmodium falciparum in Individual Patients in Western Kenya.pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.Molecular surveillance of artemisinin resistance falciparum malaria among migrant goldmine workers in MyanmarTreatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009-2013).Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province, China from AfricaMalaria 2017: Update on the Clinical Literature and Management.Molecular analysis demonstrates high prevalence of chloroquine resistance but no evidence of artemisinin resistance in Plasmodium falciparum in the Chittagong Hill Tracts of Bangladesh.Efficacy and safety of artesunate-mefloquine therapy for treating uncomplicated Plasmodium falciparum malaria: systematic review and meta-analysis.Antimalarial Drug Resistance: A Threat to Malaria Elimination.Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015.
P2860
Q28069384-C1BF8FB2-0145-49E3-8F66-1E14A329D2E4Q28069435-2866FB47-24AF-4910-BC67-A2634A5F2557Q28276294-6EFF536D-E5D1-447E-BE92-3325C1EDEAF6Q30044965-C2A2F5D4-A272-4013-913A-2695F5820062Q30240158-3E98B9BB-820F-4EC7-A2CE-3521293FF4E8Q30253026-F54A7311-BEC4-48A1-82CE-BFE27BFC8997Q33555297-CBD4983C-12C0-4D43-B8C2-1A49F43D63D5Q33607319-BC47C7B0-BBB7-4D72-8523-43FAC2C5258FQ33629027-8404BD6B-1C65-4F79-A636-4EBD0BD0E510Q33654512-B32759BD-36AE-427A-998D-09DCD21816ECQ33655603-73D71ED0-11CE-4A97-B36B-B1210E7A0ACAQ33729200-C8F6B9A8-7945-4E48-923B-DA1A60CECFC3Q33778751-624A8DCB-530F-4E53-AF14-10FEBD25250CQ33870033-0BD25334-30DD-4665-827E-642B04329BD0Q36177240-3D079FA5-8C91-4885-A53B-8A0D6A3CCB3AQ36413834-1F07691D-2B65-4639-8C3A-1E1A47FC657AQ37267688-E96B543C-BCB0-41F3-BF4D-94CD6443A891Q37305591-E105CE60-4E53-4373-86C4-50A009C500D6Q37349461-FE0A804B-B10D-4623-B478-F955FD26E244Q37349592-B80987A3-445F-4384-B50D-DD693B14CE0AQ37394719-F16D4DEC-787B-4C45-9AF4-E2234B14BF38Q37400685-E7E157A9-DD20-4A68-A709-C23DD863167CQ37408925-681633BF-A212-4178-8867-3287D33080DBQ37456812-34D208CC-4C18-4907-823D-06D3C06C3DDBQ37470416-D0D08EBE-4AD8-4634-87AD-30FD3458042CQ37476612-E4369AC4-FEE6-446D-BD80-D9710F43899DQ37566118-D7BE1CF5-E54C-455B-B9C6-243F2606FE12Q37576425-3C3080C3-B783-48CC-A8D7-563BF88C5255Q37586458-83D176C6-F90E-4785-9923-5E4095B9D9CAQ37602150-83381863-F7B3-407D-BA1F-1B7FBC08B8BDQ37669829-7B777B31-296B-4B83-876C-683165E9E384Q37676836-63CA143F-FACF-4826-AC5C-CBD1BAA1E1A2Q37722332-913F5D88-51F3-45E5-8814-CA85153624E0Q38372219-2848F7D7-1B26-4228-B1D4-15D2A5F4FDC7Q38630208-D033EA98-B38C-4306-8803-0E9147BDDD7EQ38716255-93DB5DB2-691D-4C7C-9954-FBBEBA79A10FQ38866966-D7A522E2-1765-41C6-BCB6-807FB318B03BQ39063353-B551148F-D3C6-4609-8A16-29D497BC0C78Q39176615-7CEBC3CB-BE02-40BB-8399-3EA25F1B2C42Q39504442-7F5A0613-E9F9-43D0-A425-CEDB5D59C824
P2860
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
@ast
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
@en
type
label
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
@ast
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
@en
prefLabel
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
@ast
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
@en
P2093
P2860
P50
P356
P1476
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
@en
P2093
Abdillahi M Hassan
Abdiqani Sheikh-Omar
Abebe A Fola
Alioune Dieye
Antoine Berry
Ayola A Adegnika
Barbara Stokes
Benoit Witkowski
Bouasy Hongvanthong
Bui Quang-Phuc
P2860
P304
P356
10.1056/NEJMOA1513137
P407
P50
P577
2016-06-01T00:00:00Z